Laser Treatment of Endobronchial Renal Cell Carcinoma

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Patients with endobronchial renal cell carcinoma (RCC) are at high risk for significant hemoptysis. We evaluated the palliative efficacy and risks of Nd:YAG laser phototherapy in treating such patients, and observed their survival. The medical records of all patients (n = 13) with endobronchial RCC who underwent Nd:YAG laser phototherapy from 1990 to 2003 at our institution were reviewed. Twenty-three laser procedures were performed, resulting in a 98% mean reduction in endobronchial obstruction by proximal lesions, and a 43% mean reduction in obstruction by distal lesions. All patients on mechanical ventilation (n = 2) were successfully weaned within 24 hours after laser therapy. The overall complication rate was 0.87 per procedure. Hemorrhage accounted for 60% of total complications (mean estimated blood loss, 107 ± 135.9 mL). Mean survival from date of first laser intervention was 8.8 ± 9.3 months. Patients with RCC who demonstrate respiratory symptoms ought to be promptly evaluated for an endobronchial RCC component. Nd:YAG laser phototherapy can be highly effective as a palliative procedure in patients with endobronchial RCC, despite the significant hemorrhage risk. Because potentially life-threatening hemorrhage remains the single most serious complication during bronchoscopy, these procedures ought to be performed in a tertiary referral center by bronchoscopy teams with adequate experience and expertise.

Original languageEnglish (US)
Pages (from-to)92-97
Number of pages6
JournalJournal of Bronchology
Volume11
Issue number2
DOIs
StatePublished - Apr 2004
Externally publishedYes

Fingerprint

Renal Cell Carcinoma
Lasers
Solid-State Lasers
Bronchoscopy
Hemorrhage
Therapeutics
Survival
Hemoptysis
Laser Therapy
Cellular Structures
Artificial Respiration
Tertiary Care Centers
Medical Records
Low-Level Light Therapy

Keywords

  • Bronchoscopy
  • Endobronchial
  • Metastasis
  • Nd:YAG laser
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Laser Treatment of Endobronchial Renal Cell Carcinoma. / Chan, Andrew; Juarez, Maya M.; Albertson, Timothy E; Morrissey, Brian M; Allen, Roblee P; Meyers, Frederick J.

In: Journal of Bronchology, Vol. 11, No. 2, 04.2004, p. 92-97.

Research output: Contribution to journalArticle

@article{82a7b6bed4be42cfa15926c6c379b59d,
title = "Laser Treatment of Endobronchial Renal Cell Carcinoma",
abstract = "Patients with endobronchial renal cell carcinoma (RCC) are at high risk for significant hemoptysis. We evaluated the palliative efficacy and risks of Nd:YAG laser phototherapy in treating such patients, and observed their survival. The medical records of all patients (n = 13) with endobronchial RCC who underwent Nd:YAG laser phototherapy from 1990 to 2003 at our institution were reviewed. Twenty-three laser procedures were performed, resulting in a 98{\%} mean reduction in endobronchial obstruction by proximal lesions, and a 43{\%} mean reduction in obstruction by distal lesions. All patients on mechanical ventilation (n = 2) were successfully weaned within 24 hours after laser therapy. The overall complication rate was 0.87 per procedure. Hemorrhage accounted for 60{\%} of total complications (mean estimated blood loss, 107 ± 135.9 mL). Mean survival from date of first laser intervention was 8.8 ± 9.3 months. Patients with RCC who demonstrate respiratory symptoms ought to be promptly evaluated for an endobronchial RCC component. Nd:YAG laser phototherapy can be highly effective as a palliative procedure in patients with endobronchial RCC, despite the significant hemorrhage risk. Because potentially life-threatening hemorrhage remains the single most serious complication during bronchoscopy, these procedures ought to be performed in a tertiary referral center by bronchoscopy teams with adequate experience and expertise.",
keywords = "Bronchoscopy, Endobronchial, Metastasis, Nd:YAG laser, Renal cell carcinoma",
author = "Andrew Chan and Juarez, {Maya M.} and Albertson, {Timothy E} and Morrissey, {Brian M} and Allen, {Roblee P} and Meyers, {Frederick J}",
year = "2004",
month = "4",
doi = "10.1097/00128594-200404000-00005",
language = "English (US)",
volume = "11",
pages = "92--97",
journal = "Journal of Bronchology and Interventional Pulmonology",
issn = "1944-6586",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Laser Treatment of Endobronchial Renal Cell Carcinoma

AU - Chan, Andrew

AU - Juarez, Maya M.

AU - Albertson, Timothy E

AU - Morrissey, Brian M

AU - Allen, Roblee P

AU - Meyers, Frederick J

PY - 2004/4

Y1 - 2004/4

N2 - Patients with endobronchial renal cell carcinoma (RCC) are at high risk for significant hemoptysis. We evaluated the palliative efficacy and risks of Nd:YAG laser phototherapy in treating such patients, and observed their survival. The medical records of all patients (n = 13) with endobronchial RCC who underwent Nd:YAG laser phototherapy from 1990 to 2003 at our institution were reviewed. Twenty-three laser procedures were performed, resulting in a 98% mean reduction in endobronchial obstruction by proximal lesions, and a 43% mean reduction in obstruction by distal lesions. All patients on mechanical ventilation (n = 2) were successfully weaned within 24 hours after laser therapy. The overall complication rate was 0.87 per procedure. Hemorrhage accounted for 60% of total complications (mean estimated blood loss, 107 ± 135.9 mL). Mean survival from date of first laser intervention was 8.8 ± 9.3 months. Patients with RCC who demonstrate respiratory symptoms ought to be promptly evaluated for an endobronchial RCC component. Nd:YAG laser phototherapy can be highly effective as a palliative procedure in patients with endobronchial RCC, despite the significant hemorrhage risk. Because potentially life-threatening hemorrhage remains the single most serious complication during bronchoscopy, these procedures ought to be performed in a tertiary referral center by bronchoscopy teams with adequate experience and expertise.

AB - Patients with endobronchial renal cell carcinoma (RCC) are at high risk for significant hemoptysis. We evaluated the palliative efficacy and risks of Nd:YAG laser phototherapy in treating such patients, and observed their survival. The medical records of all patients (n = 13) with endobronchial RCC who underwent Nd:YAG laser phototherapy from 1990 to 2003 at our institution were reviewed. Twenty-three laser procedures were performed, resulting in a 98% mean reduction in endobronchial obstruction by proximal lesions, and a 43% mean reduction in obstruction by distal lesions. All patients on mechanical ventilation (n = 2) were successfully weaned within 24 hours after laser therapy. The overall complication rate was 0.87 per procedure. Hemorrhage accounted for 60% of total complications (mean estimated blood loss, 107 ± 135.9 mL). Mean survival from date of first laser intervention was 8.8 ± 9.3 months. Patients with RCC who demonstrate respiratory symptoms ought to be promptly evaluated for an endobronchial RCC component. Nd:YAG laser phototherapy can be highly effective as a palliative procedure in patients with endobronchial RCC, despite the significant hemorrhage risk. Because potentially life-threatening hemorrhage remains the single most serious complication during bronchoscopy, these procedures ought to be performed in a tertiary referral center by bronchoscopy teams with adequate experience and expertise.

KW - Bronchoscopy

KW - Endobronchial

KW - Metastasis

KW - Nd:YAG laser

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=2342614860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342614860&partnerID=8YFLogxK

U2 - 10.1097/00128594-200404000-00005

DO - 10.1097/00128594-200404000-00005

M3 - Article

AN - SCOPUS:2342614860

VL - 11

SP - 92

EP - 97

JO - Journal of Bronchology and Interventional Pulmonology

JF - Journal of Bronchology and Interventional Pulmonology

SN - 1944-6586

IS - 2

ER -